On January 2, 2022, Israel began administering a fourth dose of BNT162b2 vaccine to persons 60 years of age or older. Data are needed regarding the effect of the fourth dose on rates of confirmed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results